DAU-6285

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameDAU-6285
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor antagonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsArrhythmias, CardiacGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyGermanyUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgRoche Palo Alto LlcBoehringer Ingelheim Pharma KG
Active IndicationsN/A
Inactive IndicationsArrhythmias, CardiacGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A